Data / Form D filings / Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc.: Form D filing
Kyverna Therapeutics, Inc., a biotechnology company in Emeryville, CA, filed a Form D with the SEC in 2023. The latest, on November 7, 2023, reports $152 million sold of a $152 million offering to 24 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5980 HORTON STREET, SUITE 550, Emeryville, CA, 94608
- Phone
- (510) 626-8331
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1994702
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | New notice | $151,999,981 | $151,999,981 | 24 | Nov 9, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Kotzin | Director | |
| Ian Clark | Director | |
| Ryan Jones | Executive Officer | |
| Karen Walker | Executive Officer | |
| Peter Maag | Executive Officer, Director | |
| James Chung | Executive Officer | |
| Dan Spiegelman | Director | |
| Beth Spiegelman | Director | |
| Fred Cohen | Director | |
| Steve Liapis | Director | |
| Dominic Borie | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 6, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kyverna Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.